As of Feb 23
| +0.70 / +0.87%|
The 23 analysts offering 12-month price forecasts for CVS Caremark have a median target of 88.00, with a high estimate of 104.00 and a low estimate of 77.00. The median estimate represents a +8.83% increase from the last price of 80.86.
The current consensus among 25 polled investment analysts is to Buy stock in CVS Caremark. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.